We are live on
!
Find out more
PCM
Palouse Capital Management Portfolio holdings
AUM
$160M
1-Year Est. Return
36.15%
This Fund
S&P 500
This Quarter
Est. Return
+2.71%
1 Year Est. Return
+36.15%
3 Year Est. Return
+67.75%
5 Year Est. Return
+68.17%
10 Year Est. Return
+160.38%
AUM
$286M
AUM Growth
-$9.11M
(-3.1%)
Cap. Flow
-$15.6M
Cap. Flow
% of AUM
-5.45%
Top 10 Holdings %
Top 10 Hldgs %
25.93%
Holding
116
New
14
Increased
46
Reduced
45
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco
IVZ
|
+$8.43M |
| 2 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$6.91M |
| 3 |
Molson Coors Class B
TAP
|
+$4.98M |
| 4 |
NXP Semiconductors
NXPI
|
+$2.09M |
| 5 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$745K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$8.31M |
| 2 |
Eaton
ETN
|
+$6.34M |
| 3 |
Amgen
AMGN
|
+$6.25M |
| 4 |
Welltower
WELL
|
+$4.79M |
| 5 |
Target
TGT
|
+$4.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.86% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.13% |
| 4 | Industrials | 9.71% |
| 5 | Consumer Discretionary | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PACW
76
DELISTED
PacWest Bancorp
PACW
| $287K | 0.1% |
+6,018
| New | +$303K |
|
77
ABM Industries
ABM
$2.86B
| $283K | 0.1% |
8,786
+394
| +5% | +$12.5K |
|
|
EFII
78
DELISTED
Electronics for Imaging
EFII
| $282K | 0.1% |
8,276
-390
| -5% | -$13.2K |
|
79
Belden
BDC
$5.12B
| $276K | 0.1% |
3,867
+161
| +4% | +$11.1K |
|
|
HTBK
80
DELISTED
Heritage Commerce
HTBK
| $276K | 0.1% |
18,477
-288
| -2% | -$4.56K |
|
81
East-West Bancorp
EWBC
$18B
| $273K | 0.1% |
4,518
+278
| +7% | +$17.9K |
|
82
Owens Corning
OC
$12.3B
| $272K | 0.1% |
+5,018
| New | +$302K |
|
83
Apogee Enterprises
APOG
$911M
| $271K | 0.09% |
6,559
+300
| +5% | +$14.5K |
|
84
First Horizon
FHN
$12B
| $270K | 0.09% |
15,659
+974
| +7% | +$17.6K |
|
85
Timken Company
TKR
$9B
| $266K | 0.09% |
5,327
+237
| +5% | +$11.2K |
|
86
Lifecore Biomedical
LFCR
$183M
| $265K | 0.09% |
18,410
+809
| +5% | +$11.2K |
|
87
Methode Electronics
MEI
$581M
| $263K | 0.09% |
7,273
+9
| +0.1% | +$352 |
|
|
STL
88
DELISTED
Sterling Bancorp
STL
| $259K | 0.09% |
11,774
+809
| +7% | +$18.4K |
|
89
Photronics
PLAB
$1.94B
| $257K | 0.09% |
26,107
-18,109
| -41% | -$168K |
|
90
Kelly Services Class A
KELYA
$537M
| $256K | 0.09% |
10,668
+730
| +7% | +$17.7K |
|
|
TOWR
91
DELISTED
Tower International, Inc.
TOWR
| $255K | 0.09% |
8,439
+314
| +4% | +$10.2K |
|
92
MKS Inc
MKSI
$20.8B
| $245K | 0.09% |
+3,056
| New | +$279K |
|
93
FormFactor
FORM
$9.3B
| $241K | 0.08% |
17,527
-13
| -0.1% | -$179 |
|
94
Carriage Services
CSV
$580M
| $240K | 0.08% |
11,153
+783
| +8% | +$18.4K |
|
95
Fortune Brands Innovations
FBIN
$6.15B
| $240K | 0.08% |
+5,363
| New | +$252K |
|
96
Schwab US Large- Cap ETF
SCHX
$74.3B
| $239K | 0.08% |
+20,640
| New | +$235K |
|
97
Matrix Service
MTRX
$334M
| $234K | 0.08% |
+9,489
| New | +$201K |
|
98
Western Alliance Bancorporation
WAL
$8.88B
| $232K | 0.08% |
4,076
+209
| +5% | +$12K |
|
|
ARRS
99
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $232K | 0.08% |
8,938
+508
| +6% | +$13K |
|
100
Bank OZK
OZK
$5.62B
| $229K | 0.08% |
6,024
+909
| +18% | +$37.3K |
|
Similar funds
PCC
CF
SGCM
RCWM
LCA
WHCI
FPWM
SMF
Palouse Capital Management's Q3 2018 Portfolio in Review
As of Q3 2018, Palouse Capital Management held 116 positions worth $286M, down 3.1% from $295M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Palouse Capital Management withdrew a net $15.6M in Q3 2018, closing 10 positions and reducing 45 holdings. Its most notable exit was Pfizer, an estimated $8.31M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Palouse Capital Management opened a new position in Invesco worth $7.72M.
- Palouse Capital Management's largest Q3 2018 buy was Invesco: 337,299 shares worth $7.72M.
- Palouse Capital Management added most to Molson Coors Class B in Q3 2018, an estimated $4.98M increase.
- Palouse Capital Management's biggest Q3 2018 reduction was Nucor, cutting an estimated $3.25M.
- Palouse Capital Management fully exited Pfizer in Q3 2018, selling an estimated $8.31M.
- Palouse Capital Management's ten largest holdings make up 26% of its $286M portfolio in Q3 2018.
- Palouse Capital Management opened 14 new positions and closed 10 in Q3 2018.
- Palouse Capital Management's portfolio value fell 3.1% quarter-over-quarter to $286M.
Based on Palouse Capital Management's 13F filing for Q3 2018, filed 29 Oct 2018.